Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engages in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company was founded on February 2, 2025 and is headquartered in Estero, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A market cap is $26.98M.
What is the 52-week high for Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A 52 week high is $15.80 as of September 06, 2025.
What is the 52-week low for Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A 52 week low is $0.215 as of September 06, 2025.
What is Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A stock price today?
Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A stock price today is $0.5119.
What was Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A stock price yesterday?
Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A stock price yesterday was $0.5448.
What is the PE ratio of Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A’s P/E ratio is -0.32.
What is the Price-to-Book ratio of Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A P/B ratio is -2.8056.
What is the 50-day moving average of Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aspire Biopharma Holdings Inc. - Ordinary Shares - Class A 50-day moving average is $0.407.
